The established risk of prostate cancer comorbidity in BRCA1/2 mutation carriers: where is the clinically relevant hotspot for prostate cancer?

Detalles Bibliográficos
Autores principales: Matsumoto, Takashi, Shiota, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658146/
https://www.ncbi.nlm.nih.gov/pubmed/33209696
http://dx.doi.org/10.21037/tau-20-866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658146/
https://www.ncbi.nlm.nih.gov/pubmed/33209696
http://dx.doi.org/10.21037/tau-20-866

Ejemplares similares